2015 Performance


2015 Quality Performance Results
Measure number Measure Name 2015 reporting period
ACO Mean performance rate (SSP-  ACOs)
performance rate
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 80.43 80.61
ACO-2 CAHPS: How Well Your Providers Communicate 94.74 92.65
ACO-3 CAHPS: Patients’ Rating of Provider 92.6 91.94
ACO-4 CAHPS: Access to Specialists 84.28 83.61
ACO-5 CAHPS: Health Promotion and Education 61.68 59.06
ACO-6 CAHPS: Shared Decision Making 72.95 75.17
ACO-7 CAHPS: Health Status/Functional Status 71.75 72.3
ACO-34 CAHPS: Stewardship of Patient Resources* 29.91 26.87
ACO-8 Risk Standardized, All Condition Readmission 14.40 14.86
ACO-35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)*  Readmission 16.98 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 60.65 54.60
ACO-37  All-Cause Unplanned Admissions for Patients with Heart Failure* 83.35 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 65.56 62.92
ACO-9 Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Ssthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) $5 1.61 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 1.07 1.04
ACO-11 Percent of Primary Care Physicians who Successfully Meet Meaningful Use  Requirements 57.97% 80.14%
ACO-39 Documentation of Current Medications in the Medical Record* 87.84% 84.07%
ACO-13 Falls: Screening for Future Fall Risk 87.99% 56.46%
ACO-14 Preventive Care and Screening: Influenza Immunization 62.98% 62.03%
ACO-15 Pneumonia Vaccination Status for Older Adults 62.40% 63.73%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 85.71% 71.15%
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 90.68% 90.16%
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 76.97% 45.25%
ACO-19 Colorectal Cancer Screening 61.73% 60.06%
ACO-20 Breast Cancer Screening 60.17% 65.67%
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and  Follow-Up Documented 84.49% 70.04%
ACO-40 Depression Remission at Twelve Months* 6.25% 6.11%
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 27.33% 20.38%
ACO-41 Diabetes: Eye Exam* 44.77% 41.05%
ACO-28 Hypertension: Controlling High Blood Pressure 63.24% 69.62%
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 63.02% 83.82%
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 49.62% 87.22%
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 56.57% 77.73%
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
*= Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A